WAO News and Notes - Medical Reviews
Volume 5, Issue 1
January 2008

wao journalIntroducing a new resource, the World Allergy Organization Journal (WAO Journal), the official publication of the World Allergy Organization (WAO). Packed full of original research, in-depth reviews and up-to-the-minute reports, this online-only journal offers the deal forum for allergy/immunology professionals worldwide to share knowledge and explore groundbreaking topics.

For the first six months of publication (January - June 2008), the WAO Journal will be available for FREE online. Visit www.waojournal.org now and you'll get instant access to cutting-edge discoveries published exclusively online - 24 hours a day, 7 days a week.

新しいWAOの機関誌WAO Journalが創刊されました。On-lineだけの雑誌であり、本年6月号まではFree onlineの予定です。

Make sure to sign up for eAlerts at www.waojournal.org to receive notice that a new posting of the WAO Journal is online.

Medical Journal Reviews

Prof. Richard F. Lockey, MD, WAO Web Editor-in-Chief, and Guest Reviewer Gary Hellermann, PhD, reviewed premier medical journal articles for practicing allergists. 南フロリダ大学のロッキー教授による実地医家のためのアレルギー関連医学論文のレビューです。

1. Computed tomography (CT)-an increasing source of radiation exposure.
Compared to regular X-rays, CT scans result in much higher cumulative doses of radiation. This review describes various procedures, typical doses, uses and the biological effects of ionizing radiation. No major studies of the health risks from CT scans have been done, but extrapolation from known CT doses to those received in other circumstances suggests caution, especially in light of the very large numbers of people undergoing CT procedures. Editor's comment: Because a CT results in high doses of ionized radiation, other procedures (including an extensive and accurate history and physical), such as MRI or ultrasound, may provide satisfactory diagnostic results when substituted for a CT. Brenner DJ et al., N Eng J Med 2007; 357:2277-2284.

CT断層写真における放射線曝露は通常のレ線撮影よりも多い。以前よりも手軽にCT撮影を受ける機会が増えていることに著者らは警鐘を鳴らしている。

2. Determinants of response to fluticasone propionate (FP) and salmeterol/fluticasone propionate combination (SFC) in the Gaining Optimal Asthma control (GOAL) study.
Asthmatics with uncontrolled disease were given either FP alone or SFC. The GOAL data analysis seeks to determine the factors affecting outcomes and how to better manage asthma. Subjects were categorized into totally controlled (TC), well-controlled (WC) or not well-controlled (NWC) groups. Statistical methods were used to establish the odds ratios for specific factors which reduced the chances for improvement. The primary determinant for the NWC group was smoking, even though all groups improved, especially with SFC. Editor's Comment: The take-home message is clear: tell your asthma patients, if they want to get better, they must stop smoking. Pederson SE et al., J Allergy Clin Immunol 2007; 120:1036-1042.

GOALスタディにおけるフルチカゾン単剤およびサルメテロール・フルチカゾン合剤に対する反応性を左右する因子について検討した結果、コントロール不良群では喫煙者が有意に増加していた。

3. Comparative study of budesonide inhalation suspension (BIS) and monteleukast (M) in young children with mild persistent asthma.
This study compares BIS to M over one year in children 2 to 8 yrs with mild persistent asthma. Subjects (395) in multicenter groups were randomized to receive BIS (0.5 mg) or M (4-5 mg) daily. Outcomes were length of time to first exacerbation and subsequent additional treatment for exacerbation, rates of exacerbation, PEF and QoL assessment. Both BIS and M provided good asthma control, but B was better. Editor's comment: While BIS improves asthma control better than M, the ease of use of the latter sometimes may be advantageous, particularly in young children. Szefler SJ et al., J Allergy Clin Immunol 2007; 120:1043-1050.

2歳から8歳の喘息児に対するブデソニド懸濁液とモンテルカストの効果を比較した結果、両者との有意な改善が認められたが、ブデソニドの効果の方が優れていた。しかし、編集者は「簡便さを考えるとモンテルカストに利点がある」とコメントしている。

4. Genetic effect of CCR3 and IL5RA gene polymorphisms on eosinophilia in asthmatic patients.
Two factors which affect the eosinophil numbers are the chemokine receptor, CCR3, and the eosinophil survival mediator, IL-5. In this study, single-nucleotide polymorphisms (SNPs) in the genes for CCR3 and IL-5 receptor alpha subunit in a group of 576 Korean asthmatic patients and 180 healthy persons are correlated with asthma susceptibility and eosinophilia. Among the SNPs in the CCR3 gene, all are located in introns and none are associated with asthma susceptibility. However, some asthmatic subjects with CCR3 alterations had lower eosinophil numbers compared to the more common SNPs associated with eosinophilia. IL5RA SNPs resulted in increased eosinophil numbers in asthmatic subjects and when paired with a CCR3 SNP, the effects on eosinophilia were enhanced. Editor's comment: The statistical association of specific SNPs with asthma contributes to the knowledge of asthma pathology. Lee J-H et al., J Allergy Clin Immunol 2007; 120:1110-1117.

韓国の喘息患者を対象にCCR3とIL-5受容体のSNPハプロタイプと発症の相関について検討した。その結果、喘息発症との相関は認めなかったが、喘息患者の好酸球数との間に有意な相関を認めた。そして、CCR3とIL-5受容体の遺伝子多型の好酸球数に対する影響は相加的であった。

5. Defective T-cell activation caused by impairment of the TNF receptor 2 co-stimulatory pathway in common variable immunodeficiency (CVID).
CVID is characterized by decreased production of B cells and immunoglobulins and an increased susceptibility to bacterial infections. Hereditary defects in T-cell receptor signaling are implicated, but in most cases, the exact abnormality is unknown. This paper examines the TNF-mediated co-stimulatory pathway of T-cell activation in a group of CVID patients compared to healthy controls. The CVID subjects have a normal primary TCR signal (CD69) as well as normal calcium store flux and PKC-theta activation, however, TCR co-stimulation through TNF-RII was severely impaired. Editor's comment: CVID is a complex disorder and understanding genetic defects is important to design new therapies. Aspalter RM et al., J Allergy Clin Immunol 2007; 120:1193-1200.

分類不能型免疫不全症の中で、TNF受容体の変異によるT細胞受容体の共刺激シグナル欠損が原因となるグループが発見された。

6. Genetics of Asthma: Potential implications for reducing asthma disparities.
This review presents what is known about specific gene alterations in minorities and points out areas where there are weaknesses due to small sample size or genetic and environmental heterogeneity. Polymorphisms (SNPs) in the disintegrin and metalloprotease 33 (ADAM33) gene, the IL-4 receptor, the HLA loci and others are discussed in African-American or Hispanic populations compared to whites. Significant differences in the frequency of SNPs and haplotypes are seen. Editor's comment: Elucidation of asthma pathology mechanisms depends on obtaining information on all racial groups. Scirica CV and Celedon JC, Chest 2007; 770S-781S.

喘息の遺伝学に関する総説である。ADAM33やIL-4受容体、HLA遺伝子などの遺伝子多型と喘息発症との相関に関して多くの報告があるが、人種や環境の違いにより結果が異なる場合が多いとしている。

7. Diesel-enriched particulate matter (PM) functionally activates human dendritic cells (DC).
Human DC were expanded from peripheral blood by culturing them in the presence of specific cytokines and exposed to PM from cars (gas) or trucks (diesel). The activation phenotype of the DCs was determined by flow cytometry of maturation markers and endocytosis of FITC-dextran. PM from car exhaust had little effect on DC activation, but diesel PM increased secretion of TNF, IL-6 and IFN-gamma and upregulated MHC-II. Both car and diesel exhausts promoted a Th2 cytokine response. Diesel PM specifically stimulates endocytosis by DCs which is different from other activators such as LPS. The enhanced antigen uptake combined with stimulation of maturation marker expression seems to be a unique feature of diesel exhaust and may account for some of its inflammatory effects. Editor's comment: The mechanism of diesel PM effects on DCs remains to be elucidated through additional experiments. Porter M, et al., Am J Resp Cell Mol Biol 2007; 37:706-719.

ディーゼル微粒子は樹状細胞の抗原提示能を増強する。

8. Respiratory effects of exposure to diesel traffic in persons with asthma.
A group of 60 nonsmoking asthmatics with mild to moderate symptoms were recruited and tested during a period free from exacerbations or respiratory infections. They were allowed to continue their regular medications, but not oral corticosteroids. Participants walked for about two hours in one of two areas-a busy street with heavy diesel traffic only or a park away from traffic. Air in each area was sampled and numbers and sizes of PM determined. Spirometry was performed before, during and after the sessions and subjects were asked to record asthma symptoms. Sputum samples were collected for cell counts and analysis of cytokines and ECP. Fractional exhaled NO and breath condensate pH were also measured. Results showed a greater reduction in FEV1 in subjects walking in the city area compared to the park, and moderate asthmatics had a greater drop in FEV1 than mild asthmatics. Other measurements such as decreased pH and increase in sputum myeloperoxidase also Correlated with increased PM. Editor's comment: No difference in symptoms were reported between the city and the park groups, but the extensive physical data implicate diesel PM as pro-inflammatory. McCreanor J et al., N Engl J Med 2007; 357:2348-2358.

都市部と郊外の公園付近に住む喘息患者の症状に変わりはなかったが、都市部に住む患者において一秒率の減少が認められた。

9. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Airway eosinophilia is a prevalent problem in chronic asthma and treatments that reduce IL-5, the cytokine involved in proliferation, survival, migration and maturation of eosinophils (E), seems an ideal target for anti-E therapy. This multicenter, DBPCS of the humanized anti-IL-5 antibody, mepolizumab, seems to argue against this conclusion. Subjects ranged in age from 18 to 55 years and had FEV1s of 50-80 % of predicted. Their asthma control required high doses of ICS (1000 micrograms beclomethasone or equivalent). Doses of mepolizumab, 250 or 750 mg, were given i.v. at monthly intervals and outcomes were measured in terms of FEV1, E counts in serum and sputum, diary cards and QoL questionnaires. There was a significant reduction in the tendency for exacerbation in the group receiving the highest dose of mepolizumab, but otherwise no change in other parameters was observed. Editor's comment: Further investigation into the reasons why anti-IL-5 treatment does not work for asthma may tell us more about its pathogenesis. Flood-Page P et al., Am J Resp Crit Care Med 2007; 176:1062-1071. (editorial by PM O'Byrne, pp. 1059-1060).

抗IL-5抗体の効果を以前の報告よりも規模を拡大し、様々な角度から検討した。その結果、抗IL-5抗体の効果は認めなかった。

10. Ceramide: A key signaling molecule in a guinea pig model of allergic asthmatic response and airway inflammation.
Ceramide is a membrane-associated sphingolipid that is pro-inflammatory and pro-apoptotic. Using ovalbumin-sensitized guinea pigs, the authors found that lung ceramide production was elevated after allergen challenge. Bronchoconstriction, dyspnea and cough also increased. Pretreatment with an inhibitor of ceramide synthase blocked the allergen-induced inflammatory effects and epithelial cell death. Editor's comment: Pharmacological manipulation of ceramide levels may prove to be a useful therapy for inflammatory lung disease. Masini E et al., J Pharmacol Exp Ther 2007; [Nov. 27, epub ahead of print].

セラミドはアトピー性皮膚炎皮膚において正常に比して低下していることが知られているが、著者らはモルモットにアレルゲン吸入を行う際に気道でセラミドが増加すること、セラミドで前処置することで喘息症状の惹起が遮断できることを示した。

11. Medical progress: sarcoidosis.
First described in 1899, sarcoidosis is characterized by the formation and accumulation of benign granulomas containing activated T-cells and macrophages secreting cytokines and chemokines. The clinical characteristics, different organ involvement, the differential diagnosis, sarcoidosis in children and treatment are reviewed. Editor's comment: Great review of a disease whose etiology remains elusive. Iannuzzi MC et al., N Engl J Med 2007; 357:2153-2165.

サルコイドーシスに関する最新情報が記載された総説。

WAC 2007The World Allergy Congress 2007, in Bangkok, was a huge success.
Thanks to all the wonderful participants and organizers.
We are proud to announce that there were almost 4200 participants, representing 99 countries!

Media Highlights from WAC 2007!
Photos | Speaker Interviews

Allergy Book Review

Parasites And Allergy (Chemical Immunology and Allergy Vol. 90)
Editors: Monique Capron, Francois Trottein; 2006
ISBN-10: 3-8055-7974-8
ISSN: 1660-2242

Available from: Karger
List Price: $160.00 USD

Reviewer:
Steven L. Cole, DO
Division of Allergy and Immunology, Department of Internal Medicine
University of South Florida College of Medicine and James A. Haley Veterans' Hospital, Tampa, FL

Description:
This volume of Chemical Immunology and Allergy series focuses on the correlation between helminth infections and allergic diseases. Each chapter includes an abstract and a discussion of relevant literature followed by concluding remarks.

Purpose:
The purpose of this book is to critically examine the role of parasitic infection in influencing the immune response in atopic disorders. A collection of international experts highlight the salient issues and controversies of regulatory mechanisms involved in the Th1 and Th2 response in helminthic infection.

Audience:
The scope of this book is somewhat narrow in that it is aimed primarily at researchers involved in immune mechanisms of disease, but specialists in allergy and immunology, infectious disease, and other clinicians will find it useful as well.

Features:
Each chapter includes a discussion of primary research pertinent to the authors' expertise, and focuses on cells involved in immune regulation and their relationships to various parasitic infections. There is a generous offering of diagrams depicting the mechanisms of parasitic involvement in allergic inflammation.

Assessment:
This book is a significant contribution to the debate of the role of parasites in allergic inflammation, and is a good resource for scientists and specialists in the field. Students new to the discipline of allergy and immunology will find it difficult to fully grasp many of the concepts introduced in this volume, but it will serve as a good reference guide on this topic. The charts and graphs throughout the book are well-designed, and the illustrations are effective at capturing the key concepts of the discussion.

寄生虫とアレルギーの関連に関する本である。様々な観点による総説論文が掲載されている。

Find more allergy book reviews on the WAO Website here.

The World Allergy Organization's mission is to build a global alliance of allergy societies to advance excellence in clinical care, research, education and training. Visit us on the Web at www.worldallergy.org

World Allergy Organization (WAO)
Secretariat
555 E. Wells Street, Suite 1100
Milwaukee, WI 53202-3823
Email: info@worldallergy.org

You have received this message because you are a member of a WAO Member Society, you have subscribed for the monthly e-letter or had previous contact with the World Allergy Organization. If you would prefer not to receive further messages from WAO, please reply to this message with REMOVE in the subject line.

Made possible through an unrestricted educational grant from Novartis.
novartis